Published in Open AIDS J on July 11, 2011
Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013. Clin Infect Dis (2015) 0.89
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep (2004) 2.05
Incidence of salmonellosis in patients with AIDS. J Infect Dis (1987) 2.04
Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis (1999) 1.70
Salmonellosis in patients with neoplastic disease. A review of 100 episodes at Memorial Cancer Center over a 13-year period. Arch Intern Med (1971) 1.68
Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. Clin Infect Dis (2001) 1.66
Vasculitides associated with HIV infection. J Clin Pathol (2001) 1.32
Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review. Clin Infect Dis (1997) 1.26
The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med (2001) 1.23
The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) (2002) 1.18
Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome. Arch Intern Med (1986) 1.11
Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am (1991) 1.09
Salmonella meningitis in adults infected with HIV: case report and review of the literature. Am J Med Sci (2002) 1.05
Salmonella typhimurium meningitis in an adult patient with AIDS. J Clin Pathol (2006) 0.98
Hemorrhagic complications of cerebral arteritis. Arch Neurol (1977) 0.96
Vasculitis associated with infectious agents. Curr Opin Rheumatol (1996) 0.91
Salmonella meningitis and infection with HIV. AIDS (1990) 0.91
Recurrent Salmonella enteritidis meningitis in a patient with AIDS. Scand J Infect Dis (1995) 0.89
Bacteraemias in HIV-positive patients. Lancet (1990) 0.84
Salmonella enteritidis meningitis in a first time diagnosed AIDS patient: case report. Cases J (2008) 0.82
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol (2005) 7.91
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog (2007) 4.82
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS (2006) 2.71
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol (2003) 2.36
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood (2008) 2.27
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016) 2.09
Ethical and practical considerations in providing critical care to patients with Ebola virus disease. Chest (2015) 2.05
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest (2005) 1.96
Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol (2009) 1.84
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood (2004) 1.82
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest (2005) 1.82
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials (2010) 1.75
High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med (2002) 1.74
Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials (2008) 1.65
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. J Infect Dis (2001) 1.54
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. J Infect Dis (2004) 1.37
Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol (2008) 1.36
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials. HIV Clin Trials (2006) 1.27
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. Blood (2002) 1.18
HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. J Virol (2013) 1.17
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. J Antimicrob Chemother (2010) 1.15
Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med (2016) 1.15
Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. J Acquir Immune Defic Syndr (2002) 1.13
CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clin Infect Dis (2004) 1.10
Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. J Virol (2003) 1.06
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood (2004) 1.06
CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation. J Infect Dis (2007) 1.02
Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr Med Res Opin (2008) 1.02
Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother (2008) 1.00
Interferon-alpha produces significant decreases in HIV load. J Interferon Cytokine Res (2010) 0.99
Embolic stroke secondary to cardiac papillary fibroelastoma. Neurologist (2008) 0.99
CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients. J Infect Dis (2008) 0.99
Preparing for critical care services to patients with Ebola. Ann Intern Med (2014) 0.98
A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study. PLoS Clin Trials (2006) 0.95
Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system. Stroke (2009) 0.93
Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev (2010) 0.92
Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels. AIDS (2009) 0.91
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. PLoS One (2010) 0.89
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen. AIDS (2003) 0.89
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients. AIDS (2006) 0.87
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease. AIDS (2014) 0.87
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial. AIDS (2009) 0.86
Interferon beta for primary progressive multiple sclerosis. Cochrane Database Syst Rev (2009) 0.83
Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection. AIDS (2006) 0.82
Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America. Rev Med Virol (2014) 0.82
Interferon Beta for primary progressive multiple sclerosis. Cochrane Database Syst Rev (2010) 0.81
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation. Transpl Int (2012) 0.81
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir. AIDS Res Hum Retroviruses (2013) 0.81
Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report. Ann Intern Med (2016) 0.81
The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients. J Acquir Immune Defic Syndr (2011) 0.81
Triage and management of accidental laboratory exposures to biosafety level-3 and -4 agents. Biosecur Bioterror (2009) 0.80
Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. Thyroid (2004) 0.80
Limitations of using a single postdose midazolam concentration to predict CYP3A-mediated drug interactions. J Clin Pharmacol (2008) 0.79
Recurrent adenoid cystic carcinoma in the liver: a repeated laparoscopic surgical approach. Updates Surg (2011) 0.79
[Ischemic stroke registry]. Medicina (B Aires) (2006) 0.79
Epidemiology of pediatric pneumococcal meningitis and bacteremia in Latin America and the Caribbean: a systematic review and meta-analysis. Pediatr Infect Dis J (2014) 0.78
[Retroperitoneal abscess by suppurative psoas. Case report]. Ann Ital Chir (2009) 0.77
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus. J Infect Dis (2003) 0.76
Transient global amnesia, cerebral veins, and the need to find the 'smoking gun'. Stroke (2012) 0.76
Response. Chest (2015) 0.75
The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness. J Interferon Cytokine Res (2008) 0.75
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021. MMWR Morb Mortal Wkly Rep (2022) 0.75
[Spontaneous intracranial hypotension]. Medicina (B Aires) (2006) 0.75
Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies. Nat Med (2017) 0.75
[Acute ischemic stroke in patients aged 80 or older]. Medicina (B Aires) (2007) 0.75
Transesophageal echocardiography findings in lacunar stroke. J Stroke Cerebrovasc Dis (2008) 0.75
[Spinocerebellar ataxia 7. Clinical and genetic investigation in an Argentine family]. Medicina (B Aires) (2007) 0.75